Novartis AG (NVS)

Novartis AG (NVS) is a healthcare company (drug manufacturers - general) based in Switzerland. The share price is $159.77, down 0.27% on the day, which values the company at $301.75B. Price as of 17 Nov 2026, 17:33 UTC, from Yahoo Finance.

Key facts

Share price
$159.77−0.27% today
Market value
$301.75B
P/E ratio
30.5×last 12 months
Forward P/E
16.1×
Dividend yield
2.91%
Funk Score
67/100
Against its own history
Well above its usual priceusual price $119.27
200-week average
$117.5936% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Novartis AG in more detail

NVS trades at 30.5× its last twelve months' earnings, 16.1× next year's expected earnings, 5.3× sales. Measured against its own history, the price is 34% above what its usual multiples would imply ($119.27) — well above its usual price. It sits 36% above its 200-week average of $117.59.

Its Funk Score is 67 out of 100 (financial strength 7.3, profitability 9.7, growth 7.7, value 2.0, each out of 10).

In its favour: Strong Piotroski score; Share count keeps falling.

13 of the superinvestors tracked here hold NVS, including Tweedy, Browne team (0.8% of the portfolio), Ken Fisher (0.7% of the portfolio), Primecap team (0.6% of the portfolio).

Superinvestors holding NVS

13 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:NVS vs AZN (Novartis AG vs AstraZeneca)NVS vs UNH (Novartis AG vs UnitedHealth Group)NVS vs MRK (Novartis AG vs Merck & Co)NVS vs TMO (Novartis AG vs Thermo Fisher Scientific)NVS vs ABBV (Novartis AG vs AbbVie)

All health care companies by market valueLargest companies in SwitzerlandAll stocks A–Z

Novartis AG (NVS): questions and answers

What is NVS's P/E ratio?

Novartis AG trades at 30.5× its last twelve months' earnings and 16.1× next year's expected earnings. At its fiscal year-ends over the past 4 years the P/E ranged from 14.2× to 28.6×, with a median of 17.9×.

What is NVS's PEG ratio?

Novartis AG's PEG ratio is 3.82 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Novartis AG's market cap?

Novartis AG is valued at $301.75B at a share price of $159.77.

Is NVS overvalued or undervalued?

Against its own history, NVS is well above its usual price: the price is 34% above the $119.27 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is NVS above its 200-week moving average?

Yes. NVS is 35.9% above its 200-week average of $117.59. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Novartis AG growing?

Over the last three fiscal years Novartis AG's revenue grew 9.3% a year and its earnings per share 31.1% a year.

Cite this page

Funkfolio, “Novartis AG (NVS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/NVS

Underlying data: Yahoo Finance; company filings with the SEC.